-
Phase II Study Of EUS-guided Verteporfin PDT In Solid Pancreatic Tumors
Rochester, MN
The goal of project is to target of locally advanced pancreatic cancer (LAPC) with a photodynamic therapy (PDT) to evaluate response of tumor.
-
Confirmatory Study Of Topical HyBryte™ Vs. Placebo For The Treatment Of CTCL (FLASH2)
Scottsdale/Phoenix, AZ
The purpose of this study is to evaluate the use of HyBryte, a topical photosensitizing agent, to treat patients with patch/plaque phase cutaneous T-cell lymphoma (mycosis fungoides).
-
UVA1 Phototherapy in Patients with Scleroderma-Related Raynaud’s Phenomenon
Jacksonville, FL
The purpose of this study is to to evaluate patients undergoing the FDA-approved UVA1 phototherapy for systemic sclerosis pre, post, and during treatment for changes in their Raynaud’s phenomenon (RP) burden, digital ulcerations, and piecemeal necrosis.
-
An Open-label Study Using ASP-1929 Photoimmunotherapy In Combination With Anti-PD1 Therapy In EGFR Expressing Advanced Solid Tumors
Rochester, MN
Open-label study using ASP-1929 photoimmunotherapy in combination with anti-PD1 therapy in patients with recurrent or metastatic head and neck and squamous cell cancer or advanced or metastatic cutaneous squamous cell carcinoma.